Suscribirse

Apolipoprotein E is a concentration-dependent pulmonary danger signal that activates the NLRP3 inflammasome and IL-1? secretion by bronchoalveolar fluid macrophages from asthmatic subjects - 05/08/19

Doi : 10.1016/j.jaci.2019.02.027 
Elizabeth M. Gordon, PhD a, , Xianglan Yao, MD, PhD a, , Haitao Xu, BS a, William Karkowsky, MD a, Maryann Kaler, CRNP a, Or Kalchiem-Dekel, MD a, Amisha V. Barochia, MBBS, MHS a, Meixia Gao, MD, PhD a, Karen J. Keeran, MS b, Kenneth R. Jeffries, BS b, Stewart J. Levine, MD a,
a Laboratory of Asthma and Lung Inflammation, Pulmonary Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md 
b Animal Surgery and Resources Core Facility, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md 

Corresponding author: Stewart J. Levine, MD, Laboratory of Asthma and Lung Inflammation, Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Building 10, Room 6D03, MSC 1590, Bethesda, MD 20892-1590.Laboratory of Asthma and Lung Inflammation, Pulmonary BranchNational Heart, Lung, and Blood InstituteNational Institutes of HealthBuilding 10, Room 6D03, MSC 1590BethesdaMD20892-1590

Abstract

Background

House dust mite (HDM)–challenged Apoe−/− mice display enhanced airway hyperreactivity and mucous cell metaplasia.

Objective

We sought to characterize the pathways that induce apolipoprotein E (APOE) expression by bronchoalveolar lavage fluid (BALF) macrophages from asthmatic subjects and identify how APOE regulates IL-1β secretion.

Methods

Macrophages were isolated from asthmatic BALF and derived from THP-1 cells and human monocytes.

Results

HDM-derived cysteine and serine proteases induced APOE secretion from BALF macrophages through protease-activated receptor 2. APOE at concentrations of less than 2.5 nmol/L, which are similar to levels found in epithelial lining fluid from healthy adults, did not induce IL-1β release from BALF macrophages. In contrast, APOE at concentrations of 25 nmol/L or greater induced nucleotide-binding oligomerization domain, leucine-rich repeat–containing protein (NLRP) 3 and pro–IL-1β expression by BALF macrophages, as well as the caspase-1–mediated generation of mature IL-1β secreted from cells. HDM acted synergistically with APOE to both prime and activate the NLRP3 inflammasome. In a murine model of neutrophilic airway inflammation induced by HDM and polyinosinic-polycytidylic acid, APOE reached a concentration of 32 nmol/L in epithelial lining fluid, with associated increases in BALF IL-1β levels. APOE-dependent NLRP3 inflammasome activation in macrophages was primarily mediated through a potassium efflux–dependent mechanism.

Conclusion

APOE can function as an endogenous, concentration-dependent pulmonary danger signal that primes and activates the NLPR3 inflammasome in BALF macrophages from asthmatic subjects to secrete IL-1β. This might represent a mechanism through which APOE amplifies pulmonary inflammatory responses when concentrations in the lung are increased to greater than normal levels, which can occur during viral exacerbations of HDM-induced asthma characterized by neutrophilic airway inflammation.

El texto completo de este artículo está disponible en PDF.

Key words : Asthma, apolipoprotein E, house dust mite, IL-1β, macrophages, NLRP3 inflammasome

Abbreviations used : APOE, ASC, BALF, ELF, HDM, HMDM, M-CSF, NF-κB, NHLBI, NLRC, NLRP, PAR, PMA, poly(I:C), P2RX7, TLR


Esquema


 This research was funded by the Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.
 Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest.


© 2019  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 144 - N° 2

P. 426 - août 2019 Regresar al número
Artículo precedente Artículo precedente
  • Loss of bronchoprotection with ICS plus LABA treatment, ?-receptor dynamics, and the effect of alendronate
  • Juan Carlos Cardet, Xiaofeng Jiang, Quan Lu, Norma Gerard, Kristen McIntire, Homer A. Boushey, Mario Castro, Vernon M. Chinchilli, Christopher D. Codispoti, Anne-Marie Dyer, Fernando Holguin, Monica Kraft, Stephen Lazarus, Robert F. Lemanske, Njira Lugogo, Dave Mauger, Wendy C. Moore, James Moy, Victor E. Ortega, Stephen P. Peters, Lewis J. Smith, Julian Solway, Christine A. Sorkness, Kaharu Sumino, Michael E. Wechsler, Sally Wenzel, Elliot Israel, AsthmaNet Investigators
| Artículo siguiente Artículo siguiente
  • Integrative analysis of the intestinal metabolome of childhood asthma
  • Kathleen A. Lee-Sarwar, Rachel S. Kelly, Jessica Lasky-Su, Robert S. Zeiger, George T. O'Connor, Megan T. Sandel, Leonard B. Bacharier, Avraham Beigelman, Nancy Laranjo, Diane R. Gold, Scott T. Weiss, Augusto A. Litonjua

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.